Last updated on September 2017

A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer


Brief description of study

A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Detailed Study Description

The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.

For Study Locations, Click Here

Clinical Study Identifier: TX153154

Find a site near you

Start Over

Research Center

Located in: Additional Locations, XX Argentina
7.12miles
  Connect »